Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy, Safety, and Tolerability of JNJ-42160443 in Subjects With Interstitial Cystitis/ Painful Bladder Syndrome
Conditions
Interventions
Placebo
JNJ-42160443
Locations
25
United States
Birmingham, Alabama, United States
Phoenix, Arizona, United States
Glendora, California, United States
San Diego, California, United States
Aventura, Florida, United States
Eagle, Idaho, United States
Start Date
April 6, 2010
Primary Completion Date
June 24, 2011
Completion Date
June 24, 2011
Last Updated
October 18, 2021
NCT05694793
NCT07378358
NCT06237920
NCT05508165
NCT06531473
NCT05153694
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions